Barriers to adequate follow-up during adjuvant therapy may be important factors in the worse outcome for Black women after breast cancer treatment

Table 3 Patterns of Breast Surgery, Axillary Staging, and Adjuvant Therapy.

Disease	Treatment	Black	Other
DCIS	BCT	15/26 (58%)	14/24 (58%)
	MAST	9/26 (34%)	7/24 (29%)
	MAST-R	2/26 (8%)	3/24 (13%)
Invasive	BCT	57/124 (46%)	41/91 (45%)
	MAST	54/124 (44%)	33/91 (36%)
	MAST-R	13/124 (10%)	17/91 (19%)
Invasive	SLNB	51/124 (41%)	34/91 (38%)
	SLNB + ALND	30/124 (24%)	31/91 (34%)
	ALND	39/124 (32%)	22/91 (24%)
	None	4/124 (3%)	4/91 (4%)
Invasive	CT	91/124 (73%)	65/91 (71%)
	RT	76/124 (61%)	54/91 (59%)
	HT	67/124 (54%)	53/91 (58%)
	NC	19/124 (15%)	3/91 (3%) *

Key: BCT – breast conservation therapy, MAST – mastectomy, MAST-R – mastectomy with reconstruction, SLNB – sentinel lymph node biopsy only, SLNB + ALND – sentinel lymph node biopsy and axillary node dissection, ALND – axillary node dissection only, CT – Chemotherapy offered and accepted, RT – radiation therapy offered and accepted, HT – Hormonal therapy offered and accepted, NC – noncompliance with offered adjuvant therapy.
* The difference in the incidence of noncompliance was statistically significant, p < .01.

ISSN: 1477-7819